Radio frequency ablation of renal tumors in patients with metastatic renal cell carcinoma

Journal of Urology

Volumn 184, Issue 5, 2010, Pages 1882-1887

  Karam, Jose A ^a   Ahrar, Kamran ^b   Wood, Christopher G ^a   Jonasch, Eric ^b   Vikram, Raghunandan ^b   Romero, Claudio ^a   Tannir, Nizar ^b   Matin, Surena F ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Carcinoma, renal cell; Catheter ablation; Kidney; Mortality; Neoplasm metastasis

Indexed keywords

BEVACIZUMAB; CAPECITABINE; DOCETAXEL; DOXORUBICIN; FLUOROURACIL; GEMCITABINE; IFOSFAMIDE; INTERFERON; SORAFENIB; SUNITINIB; THALIDOMIDE;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER RECURRENCE; CLINICAL ARTICLE; DEMOGRAPHY; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HUMAN; KIDNEY CARCINOMA; KIDNEY TUMOR; MALE; METASTASIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; PRIMARY TUMOR; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REMISSION; RETROSPECTIVE STUDY; SAFETY; SURVIVAL RATE; TUMOR BIOPSY; CARCINOMA, RENAL CELL; CATHETER ABLATION; KIDNEY NEOPLASMS; MIDDLE AGED; PATHOLOGY; SECONDARY;

ADULT; AGED; CARCINOMA, RENAL CELL; CATHETER ABLATION; FEASIBILITY STUDIES; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 77957826976     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2010.06.109     Document Type: Article

References (30)

1. A.J. Pantuck, A. Zisman, and A.S. Belldegrun The changing natural history of renal cell carcinoma J Urol 166 2001 1611
2. R.C. Flanigan Debulking nephrectomy in metastatic renal cancer Clin Cancer Res 10 2004 6335S
3. R.C. Flanigan, S.E. Salmon, and B.A. Blumenstein Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer N Engl J Med 345 2001 1655
4. G.H. Mickisch, A. Garin, and H. van Poppel Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial Lancet 358 2001 966
5. R.C. Flanigan, G. Mickisch, and R. Sylvester Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis J Urol 171 2004 1071
6. A.E. Krambeck, B.C. Leibovich, and C.M. Lohse The role of nephron sparing surgery for metastatic (pM1) renal cell carcinoma J Urol 176 2006 1990
7. G.C. Hutterer, J.J. Patard, and M. Colombel Cytoreductive nephron-sparing surgery does not appear to undermine disease-specific survival in patients with metastatic renal cell carcinoma Cancer 110 2007 2428
8. U. Capitanio, L. Zini, and P. Perrotte Cytoreductive partial nephrectomy does not undermine cancer control in metastatic renal cell carcinoma: a population-based study Urology 72 2008 1090
9. D.A. Gervais, F.J. McGovern, and R.S. Arellano Radiofrequency ablation of renal cell carcinoma: part 1, indications, results, and role in patient management over a 6-year period and ablation of 100 tumors AJR Am J Roentgenol 185 2005 64
10. R.J. Zagoria, M.A. Traver, and D.M. Werle Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas AJR Am J Roentgenol 189 2007 429
11. A. Gupta, J.D. Raman, and R.J. Leveillee General anesthesia and contrast-enhanced computed tomography to optimize renal percutaneous radiofrequency ablation: multi-institutional intermediate-term results J Endourol 23 2009 1099
12. R.F. Sanchez-Ortiz, N. Tannir, and K. Ahrar Spontaneous regression of pulmonary metastases from renal cell carcinoma after radio frequency ablation of primary tumor: an in situ tumor vaccine? J Urol 170 2003 178
13. K.M. Jacobsohn, K. Ahrar, and C.G. Wood Is radiofrequency ablation safe for solitary kidneys? Urology 69 2007 819
14. S.F. Matin, K. Ahrar, and J.A. Cadeddu Residual and recurrent disease following renal energy ablative therapy: a multi-institutional study J Urol 176 2006 1973
15. A.S. Levey, J.P. Bosch, and J.B. Lewis A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation Modification of Diet in Renal Disease Study Group Ann Intern Med 130 1999 461
16. G. Hudes, M. Carducci, and P. Tomczak Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma N Engl J Med 356 2007 2271
17. M.E. Gore, C. Szczylik, and C. Porta Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial Lancet Oncol 10 2009 757
18. E.J. Abel, and C.G. Wood Cytoreductive nephrectomy for metastatic RCC in the era of targeted therapy Nat Rev Urol 6 2009 375
19. W.F. Spencer, W.M. Linehan, and M.M. Walther Immunotherapy with interleukin-2 and alpha-interferon in patients with metastatic renal cell cancer with in situ primary cancers: a pilot study J Urol 147 1992 24
20. C.N. Robertson, W.M. Linehan, and H.I. Pass Preparative cytoreductive surgery in patients with metastatic renal cell carcinoma treated with adoptive immunotherapy with interleukin-2 or interleukin-2 plus lymphokine activated killer cells J Urol 144 1990 614
21. B.I. Rini, and S.C. Campbell The evolving role of surgery for advanced renal cell carcinoma in the era of molecular targeted therapy J Urol 177 2007 1978
22. B.I. Rini VEGF-targeted therapy in metastatic renal cell carcinoma Oncologist 10 2005 191
23. N. Kawata, H. Yagasaki, and H. Yuge Histopathologic analysis of angiogenic factors in localized renal cell carcinoma: the influence of neoadjuvant treatment Int J Urol 8 2001 275
24. J.W. Slaton, K. Inoue, and P. Perrotte Expression levels of genes that regulate metastasis and angiogenesis correlate with advanced pathological stage of renal cell carcinoma Am J Pathol 158 2001 735
25. M.H. den Brok, R.P. Sutmuller, and R. van der Voort In situ tumor ablation creates an antigen source for the generation of antitumor immunity Cancer Res 64 2004 4024
26. A. Zerbini, M. Pilli, and A. Penna Radiofrequency thermal ablation of hepatocellular carcinoma liver nodules can activate and enhance tumor-specific T-cell responses Cancer Res 66 2006 1139
27. S.A. Dromi, M.P. Walsh, and S. Herby Radiofrequency ablation induces antigen-presenting cell infiltration and amplification of weak tumor-induced immunity Radiology 251 2009 58
28. C. Napoletano, F. Taurino, and M. Biffoni RFA strongly modulates the immune system and anti-tumor immune responses in metastatic liver patients Int J Oncol 32 2008 481
29. A. Zerbini, M. Pilli, and F. Fagnoni Increased immunostimulatory activity conferred to antigen-presenting cells by exposure to antigen extract from hepatocellular carcinoma after radiofrequency thermal ablation J Immunother 31 2008 271
30. Matin SF, Sharma P, Gill IS, et al. Immunological response to renal cryoablation in an in vivo orthotopic renal cell carcinoma murine model. J Urol 183: 333.